Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRINCETON, N.J., Nov. 13, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
PRINCETON, N.J., Oct. 20, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
PRINCETON, N.J., Oct. 16, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
SpectralAI has already landed $130 million in government contracts for its artificial intelligence wound care assessment technology.